Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
IR
iRhythm Holdings, Inc. Common Stock
IRTC
Mkt Cap
$3.58B
Volume
335.79K
Next Earnings
October 29th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
IR
IRTC
IR
iRhythm Holdings, Inc. Common Stock
IRTC
News
·
Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?
Mkt Cap
$3.60B
Volume
335.79K
Next Earnings
October 29th
Chart
Financials
Earnings
News
About
Insider
Filings
Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?
Tempus AI (TEM) shares gained 17.9% over the past month, outperforming peers like Claritev and iRhythm, driven by strong demand for healthcare AI. The company reported 28% revenue growth in its Data and Applications segment to $93.2M in Q2, with Insights revenues up 36%. However, TEM trades at a premium valuation of 6.59X sales versus the industry average of 4.70X, and its growth depends heavily on regulatory approvals and reimbursement decisions. Analysts recommend current holders maintain positions while prospective investors wait for a more favorable entry point.
Zacks Investment Research · Oct 9, 2026
Shipping Association of New York and New Jersey Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Personal Data Is Exposed
Edelson Lechtzin LLP is investigating a data breach at the Shipping Association of New York and New Jersey after unauthorized access on May 27, 2026 exposed personal information of benefit plan participants. The Qilin ransomware group claimed responsibility for the theft. Affected data may include names, Social Security numbers, driver's license numbers, and medical information. The law firm is offering free case evaluations for potential class action claims.
GlobeNewswire Inc. · Oct 7, 2026
iRhythm Holdings Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Patient Data Is Exposed
iRhythm Holdings, a San Francisco-based heart-monitoring company, suffered a data breach in June 2026 affecting approximately 8 million patients. Unauthorized access to third-party business applications exposed sensitive patient information including names, contact details, insurance numbers, and device serial numbers. The company disclosed the incident to the SEC and began notifying affected individuals in October 2026. A national class action law firm is investigating potential claims for compensation.
GlobeNewswire Inc. · Oct 6, 2026
iRhythm Investigates Cyber Incident After Hackers Claim Access To Sensitive Data
iRhythm Holdings disclosed a cybersecurity incident involving unauthorized access to sensitive data on third-party-hosted business applications. A threat actor claimed possession of proprietary company data and patient health information, demanding payment to prevent public disclosure. The company confirmed data exfiltration but stated core operations, clinical systems, and patient safety remain unaffected. iRhythm maintains cybersecurity insurance and does not believe the incident will materially impact financial results.
Benzinga · Jun 16, 2026
iRhythm Tech's Stock Selloff Went Too Far After Preliminary Update: Analyst
iRhythm Technologies reported strong preliminary Q4 2025 results with full-year revenue exceeding guidance and 2026 guidance of $870-880M (17-18% YoY growth). However, the stock fell ~20% due to the delay of Zio MCT launch to 2027 and 2026 guidance missing Street expectations. William Blair analyst Brandon Vazquez believes the selloff is overblown and maintains an Outperform rating, adding the stock to their Conviction List at 7x 2026 sales valuation.
Benzinga · Jan 14, 2026
NEXGEL (NXGL) Q3 2025 Earnings Call Transcript
NEXGEL reported stable Q3 2025 revenue of $2.9 million, improved gross profit margins, and narrowed adjusted EBITDA losses. The company signed new partnerships, launched product lines, and received non-dilutive financing from Stada, positioning for potential growth in Q4.
The Motley Fool · Nov 11, 2025
Global Cardiac Monitoring Devices Market to Cross USD 30 Billion by 2032, Driven by Telehealth and Remote Monitoring Trends | DelveInsight
The global cardiac monitoring devices market is projected to grow from USD 21 billion in 2024 to USD 32 billion by 2032, driven by rising cardiovascular disease prevalence, technological advancements in remote monitoring, and increasing health awareness.
GlobeNewswire Inc. · Oct 30, 2025
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service
A clinical trial showed home-based long-term continuous ECG monitoring using Zio device increased atrial fibrillation detection and reduced time to diagnosis in patients aged 65+ with moderate to high stroke risk.
GlobeNewswire Inc. · Aug 29, 2025
Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss
A shareholder filed a class action lawsuit against iRhythm Technologies, Inc. (IRTC), a digital healthcare company, alleging that the company misled investors about its Zio AT monitor. The court denied the defendants' motion to dismiss, allowing the litigation to proceed.
GlobeNewswire Inc. · Jun 18, 2025
Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032 | DelveInsight
The AI in remote patient monitoring market is witnessing strong growth, driven by the increasing prevalence of chronic illnesses and a rise in product innovation, global investments in digital health infrastructure, and a focus on proactive, data-centric healthcare approaches.
GlobeNewswire Inc. · Jun 4, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
IR
IRTC
iRhythm Holdings, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
IRTC
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any IRTC yet.
Related Tickers
Earnings